Rocket Lab's Neutron Debut Pushed to 2027: Inside the Composite Flaw That Reset the Clock
Published on 10/16/2026 at 09:11 | Editorial boerse-global.deRocket Lab has spent years telling investors that the Neutron is the vehicle that turns a small-satellite specialist into a full-spectrum launch company. On Wednesday evening, that story got a new timeline — and the market wasted little time repricing it.
The medium-lift rocket's maiden flight, previously targeted for the fourth quarter of 2026, will now slip to 2027 at the earliest. The culprit is a manufacturing defect in the forward carbon-fiber dome of the first stage's fuel tank, where microscopic air pockets and voids were found trapped between the composite layers during quality inspections. The discovery follows a tank rupture during a hydrostatic pressure test in January 2026, an event that already forced Rocket Lab to rework both its design and its production methods.
CEO Peter Beck's decision to halt and fix rather than push ahead is the kind of call that costs a quarter but can save a program. A rear dome built under the revised process has already cleared inspection, and a new forward component is now in production. Even so, a demanding test campaign still lies ahead.
A 7.2% Drop, and a 63% Gap to the High
Investors registered their displeasure immediately. The stock closed Wednesday's German session at EUR 49.30, a single-day loss of 7.2%, and pre-market trading on Thursday put it at EUR 49.95. Measured against its 52-week high of EUR 133.80, the shares now sit 63% lower — a valuation that fairly radiates skepticism.
The sell-side moved fast. KeyBanc trimmed its price target from USD 135 to USD 100 while keeping an Overweight rating, and Clear Street cut its own target from USD 129 to USD 105. Both adjustments carry the same message: the cash flows tied to Neutron are now further out than previously modeled.
Should investors sell immediately? Or is it worth buying Rocket Lab?
That delay has a direct earnings consequence. Management has said it expects positive adjusted operating income only in the quarter after a successful Neutron debut, with positive free cash flow arriving 18 to 24 months after that. The lean stretch just got longer than most market participants had penciled in only days ago.
The Case for Patience
Not everyone reads the slip as a thesis-breaker. Andres Sheppard of Cantor Fitzgerald reiterated his Buy rating and held his USD 122 target, pointing to an unchanged long-term appetite for orbital transport capacity worldwide.
The numbers behind that view are not trivial. Rocket Lab closed the second quarter of 2026 with a record backlog of USD 2.36 billion, up 137% year over year. More than 90 launches are under contract across its programs, and the workhorse Electron rocket has strung together 56 consecutive successful missions. The space systems segment, meanwhile, has become the company's stronger earnings pillar, posting a 94% revenue jump to USD 189.5 million in Q2 2026. A multi-year agreement with Synspective covering 20 launches adds further ballast.
Institutional money appears to share the longer view. ARK Invest used Wednesday's selloff to add more than 168,000 shares.
What Neutron Has to Prove
The stakes are easy to state and hard to execute. Neutron is designed to carry up to 13,000 kilograms to low Earth orbit, putting it in direct competition with SpaceX's Falcon 9. Electron, with a payload of roughly 300 kilograms, has run into natural volume limits — which is why the bigger rocket is the central growth engine for the years ahead.
The pivotal question now is whether the composite problem is genuinely isolated or the first link in a longer chain of setbacks. The company still must demonstrate a fully functional first stage powered by nine Archimedes engines generating about 6.45 million newtons of thrust, complete engine and stage qualification, and run a launch campaign from Wallops Island in Virginia. Cryogenic and hydrostatic load tests will need to wrap up cleanly by the first quarter of 2027 for the schedule to hold. Every additional month of delay drains development resources and pushes back the first commercial flight that long-term profitability depends on.
Rocket Lab at a turning point? This analysis reveals what investors need to know now.
The Bear Case: A Pattern of Slippage
Skeptics have history on their side. Neutron's debut has been postponed repeatedly, with an initial 2024 target long since abandoned. If the newly laminated dome shows fresh delamination or material weaknesses under pressure testing, the launch could slide deep into the second half of 2027 or beyond.
That scenario would cast a shadow over company revenue — projected at USD 250 million to USD 265 million for the third quarter of 2026 — in subsequent periods, and weigh on full-year 2027 estimates. Heavy upfront spending on Archimedes engine qualification and the Virginia ground infrastructure is already drawing on liquidity. And if Rocket Lab's entry into the lucrative medium-lift segment keeps receding, waiting satellite operators may simply take their contracts elsewhere.
The Next Hard Date
Technically, the chart holds as long as the stock defends its recent level, keeping the broader upside narrative for the coming year intact. A deeper correction, though, would erode confidence in management's scheduling and open the door to a retest of the yearly lows.
The next real milestone is completion of the dome manufacturing by the end of 2026. If first-stage assembly and integration come off without a hitch in the first quarter of 2027, the market finally gets what it has been waiting for: a credible, firm date for the debut flight. Spaceflight offers no risk-free path — not on the pad, and not on the ticker.
Ad
Rocket Lab Stock: New Analysis - 16 October
Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
